课题基金 / 基金详情

Combination of radiation and suicide gene therapy with radio-sensitized promoter/Endotherial precursor cell in glioma

Combination of radiation and suicide gene therapy with radio-sensitized promoter/Endotherial precursor cell in glioma
放射增敏启动子/内皮前体细胞联合放射治疗和自杀基因治疗治疗神经胶质瘤
批准号:
14571350
负责人:
OGA Masaru
金额:
$1.34万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
在第一年,我们证实了位于辐射敏化启动子下游的基因表达确实会被辐射放大。我们构建了含E_4/CMV嵌合放射增敏启动子(E_4:位于Egr-1基因的CArG元件的四重重复结构)的EGFP和HSV-tk载体。将E_4/EGFP基因转染U251-MG/U373-MG细胞,3Gy照射后,荧光显微镜下观察EGFP的表达,Western blotting检测EGFP的表达。结果,我们证实,与照射前阶段相比,在6 × 54小时后,EGFP的表达扩增了约1.3 × 1.4倍。将E4/HSV-tk和HSV-tk分别转染U251-MG/U373-MG胶质瘤细胞系,MTT法检测GCV照射后(1、3、5Gy)细胞增殖情况。结果表明:(1)放射增敏启动子也能被物理或化学刺激激活; 2)E_4/HSV-tk组仅出现辐射剂量依赖性的细胞凋亡,但无统计学意义,第二年我们用<9ns-2>辐射增敏作用强于E_4的E_4替换启动子,进行同样的实验。但与预期相反,在E_ /EGFP -处理组中,EGFP的表达并没有显著增加<9ns-2>。MTT法也未证实E_<9ns-2>/HSV-tk对胶质瘤细胞株的增殖有明显抑制作用。本研究拟以E_4/CMV为放射增敏启动子,将E_4/HSV-tk基因导入C6和内皮前体细胞系,进一步推进我们的研究计划。
英文摘要
In the first year we verified that the gene expression located at the downstream of radio-sensitized promoter would actually amplify by radiation. We constructed the EGFP&HSV-tk vectors containing E_4/CMV chimeric radio-sensitized promoter (E_4: four-repeated structure of CArG element located at Egr-1 gene). E_4/EGFP was transferred into U251-MG/U373-MG human glioma cell line respectively and the expression of EGFP was evaluated by optical observation under fluorescent microscopy and Western blotting after 3Gy irradiation. As a result, we verified that the expression of EGFP was amplified about 1.3〜1.4 times after 6〜54 hours compared to pre-irradiation stage. Then E4/HSV-tk and HSV-tk were transferred into U251-MG/U373-MG human glioma cell line respectively, and the degree of cell proliferation was evaluated by MTT assay after irradiation (1,3,5Gy) following GCV administration. The results were 1)the radio-sensitized promoter also could be activated by physical/chemical stimuli. 2)the radiation dose-dependent apoptosis was observed only in the E_4/HSV-tk-administrative group but not statistically significant.In the second year, we replaced the promoter with E_<9ns-2>, stronger than E_4 in radio-sensitization and did the same trial. Contrary to the expectation, however, the expression of EGFP was not significantly amplified in the E_<9ns-2>/EGFP -administrative groups. In the MTT assay, we also could not verified the significant inhibition of the cell proliferation among E_<9ns-2>/HSV-tk-administrative glioma cell lines after irradiation. We are going to promote our previously scheduled plan by using E_4/CMV as the radio-sensitized promoter, transferring E_4/HSV-tk into C6 and endothelial precursor cell line.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Egr-1通过DMT1激活NCOA4/FTH1通路诱导铁自噬促进铁死亡在阿尔茨海默病中的作用及分子机制
  • 批准号:
    82560270
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    32.00万元
  • 批准年份:
    2025
  • 负责人:
    黄忠仕
  • 依托单位:
五行音乐羽调对恐惧模型小鼠5-HT/EGR-1/ChAT及“杏仁核”谷氨酸毒性变化的研究
  • 批准号:
    82374556
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    李丽
  • 依托单位:
p38 MAPK/Elk-1/Egr-1信号轴介导ASM激活所致的细胞泛凋亡PANoptosis在随意皮瓣缺血坏死中的作用及机制研究
  • 批准号:
    82372540
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    周凯亮
  • 依托单位:
运用干细胞(类器官)青光眼模型研究Egr-1/c-Fos轴在视神经损伤与修复中的机制
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    唐明君
  • 依托单位: